Free CBIC CIC Practice Exam with Questions & Answers | Set: 6

Postoperative infections in clean surgical operations, defined by the Centers for Disease Control and Prevention (CDC) as uninfected operative wounds with no inflammation and no entry into sterile tracts (e.g., gastrointestinal or respiratory systems), are influenced by various perioperative factors. The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes identifying and mitigating risk factors in the "Prevention and Control of Infectious Diseases" domain, aligning with CDC guidelines for surgical site infection (SSI) prevention. The question focuses on identifying a procedure not documented as a contributor to SSIs, requiring an evaluation of evidence-based risk factors.

Option C, "The use of iodophors for preoperative scrubs," has not been documented to contribute to the development of postoperative infections in clean surgical operations. Iodophors, such as povidone-iodine, are antiseptic agents used for preoperative skin preparation and surgical hand scrubs. The CDC’s "Guideline for Prevention of Surgical Site Infections" (1999) and its 2017 update endorse iodophors as an effective method for reducing microbial load on the skin, with no evidence suggesting they increase SSI risk when used appropriately. Studies, including those cited by the CDC, show that iodophors are comparable to chlorhexidine in efficacy for preoperative antisepsis, and their use is a standard, safe practice rather than a risk factor.

Option A, "Prolonged preoperative hospital stay," is a well-documented risk factor. Extended hospital stays prior to surgery increase exposure to healthcare-associated pathogens, raising the likelihood of colonization and subsequent SSI, as noted in CDC and surgical literature (e.g., Mangram et al., 1999). Option B, "Prolonged length of the operations," is also a recognized contributor. Longer surgical durations are associated with increased exposure time, potential breaches in sterile technique, and higher infection rates, supported by CDC data showing a correlation between operative time and SSI risk. Option D, "Shaving the site on the day prior to surgery," has been documented as a risk factor. Preoperative shaving, especially with razors, can cause microabrasions that serve as entry points for bacteria, increasing SSI rates. The CDC recommends avoiding shaving or using clippers immediately before surgery to minimize this risk, with evidence from studies like those in the 1999 guideline showing higher infection rates with preoperative shaving.

The CBIC Practice Analysis (2022) and CDC guidelines focus on evidence-based practices, and the lack of documentation linking iodophor use to increased SSIs—coupled with its role as a preventive measure—makes Option C the correct answer. The other options are supported by extensive research as contributors to SSI development in clean surgeries.

The CBIC Certified Infection Control Exam Study Guide (6th edition) emphasizes that the most important consideration in assigning expiration dates to sterile supplies is package integrity, reflecting the principle of event-related sterility. Modern infection prevention practice recognizes that sterility is not determined by time alone but by whether an event has occurred that compromises the sterile barrier system.

Sterile items remain sterile indefinitely as long as the packaging remains intact, dry, and properly stored, and no contamination event (such as tearing, puncture, moisture exposure, or improper handling) has occurred. Therefore, the presence or absence of a printed expiration date is less important than assurance that the package integrity has been maintained throughout storage and handling.

Option A is correct because it captures the foundational concept that sterility is directly linked to the integrity of the packaging, not an arbitrary time frame. Option B is incorrect because fixed time-based expiration dates (e.g., 30–90 days) are outdated and not evidence-based. Options C and D may influence packaging durability or compatibility with sterilization methods, but they are secondary considerations and do not override the primary determinant of sterility.

For the CIC® exam, this question reinforces a critical sterilization principle: event-related shelf life is the standard, and infection preventionists should focus on policies that emphasize package integrity, proper storage conditions, and handling practices rather than routine time-based expiration dating.

The correct answer is A, "Observe all steps for reprocessing," as this is the most important process for the infection preventionist (IP) to review when evaluating a third-party reprocessor for single-use devices. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, the reprocessing of single-use devices (SUDs) by third-party entities must adhere to stringent infection control standards to ensure they are safe for reuse and do not contribute to healthcare-associated infections (HAIs). Observing all steps—such as cleaning, disinfection, sterilization, packaging, and quality control—allows the IP to directly assess compliance with manufacturer instructions, regulatory requirements (e.g., FDA guidelines), and best practices (e.g., AAMI ST91) (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This hands-on evaluation is critical because any deviation in the reprocessing chain can compromise device sterility and patient safety.

Option B (review the facility's blueprints and policies) provides context about the physical layout and procedural framework, but it is a preliminary step that does not directly verify the reprocessing process’s effectiveness. Option C (ensure air and water cultures are performed regularly) is important for monitoring environmental contamination risks, particularly in sterile processing areas, but it is a supportive measure rather than the primary focus of evaluating the reprocessor’s core activities. Option D (obtain feedback from other IPs who use the reprocessor) offers valuable peer insights, but it is subjective and secondary to direct observation, which provides firsthand evidence of compliance and performance.

The priority on observing reprocessing steps aligns with CBIC’s emphasis on ensuring the safety and efficacy of reprocessed medical devices, a key responsibility for IPs when outsourcing to third-party reprocessors (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.5 - Evaluate the environment for infection risks). This process enables the IP to identify specific weaknesses, validate adherence to standards, and make informed decisions about the reprocessor’s suitability.

Chlorhexidine soap is a widely used antiseptic agent in healthcare settings for hand hygiene and skin preparation due to its effective antimicrobial properties. The Certification Board of Infection Control and Epidemiology (CBIC) underscores the importance of proper hand hygiene and antiseptic use in the "Prevention and Control of Infectious Diseases" domain, aligning with guidelines from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). Understanding the microbial activity of chlorhexidine is essential for infection preventionists to recommend its appropriate use.

Option D, "Persistent activity with a broad spectrum effect," is the true statement. Chlorhexidine exhibits a broad spectrum of activity, meaning it is effective against a wide range of microorganisms, including gram-positive and gram-negative bacteria, some fungi, and certain viruses. Its persistent activity is a key feature, as it binds to the skin and provides a residual antimicrobial effect that continues to inhibit microbial growth for several hours after application. This residual effect is due to chlorhexidine’s ability to adhere to the skin’s outer layers, releasing slowly over time, which enhances its efficacy in preventing healthcare-associated infections (HAIs). The CDC’s "Guideline for Hand Hygiene in Healthcare Settings" (2002) and WHO’s "Guidelines on Hand Hygiene in Health Care" (2009) highlight chlorhexidine’s prolonged action as a significant advantage over other agents like alcohol.

Option A, "As fast as alcohol," is incorrect. Alcohol (e.g., 60-70% isopropyl or ethyl alcohol) acts rapidly by denaturing proteins and disrupting microbial cell membranes, providing immediate kill rates within seconds. Chlorhexidine, while effective, has a slower onset of action, requiring contact times of 15-30 seconds or more to achieve optimal microbial reduction. Its strength lies in persistence rather than speed. Option B, "Can be used with any hand lotion," is false. Chlorhexidine’s activity can be diminished or inactivated by certain hand lotions or creams containing anionic compounds (e.g., soaps or moisturizers with high pH), which neutralize its cationic properties. The CDC advises against combining chlorhexidine with incompatible products to maintain its efficacy. Option C, "Poor against gram positive bacteria," is incorrect. Chlorhexidine is highly effective against gram-positive bacteria (e.g., Staphylococcus aureus) and is often more potent against them than against gram-negative bacteria due to differences in cell wall structure, though it still has broad-spectrum activity.

The CBIC Practice Analysis (2022) supports the use of evidence-based antiseptics like chlorhexidine, and its persistent, broad-spectrum activity is well-documented in clinical studies (e.g., Larson, 1988, Journal of Hospital Infection). This makes Option D the most accurate statement regarding chlorhexidine soap’s microbial activity.

Hand hygiene is a cornerstone of infection prevention, and declining compliance rates pose a significant risk for healthcare-associated infections (HAIs). The Certification Board of Infection Control and Epidemiology (CBIC) emphasizes improving hand hygiene adherence in the "Prevention and Control of Infectious Diseases" domain, aligning with the Centers for Disease Control and Prevention (CDC) "Guideline for Hand Hygiene in Healthcare Settings" (2002). The IP’s survey identifies hand dryness as the primary barrier, likely due to the frequent use of alcohol-based hand sanitizers or soap, which can dehydrate skin. The goal is to address this barrier effectively while maintaining infection control standards.

Option B, "Provide a compatible lotion in a convenient location," is the most appropriate step. The CDC and World Health Organization (WHO) recommend using moisturizers to mitigate skin irritation and dryness, which can improve hand hygiene compliance. However, the lotion must be compatible with alcohol-based hand rubs (e.g., free of petroleum-based products that can reduce sanitizer efficacy) and placed in accessible areas (e.g., near sinks or sanitizer dispensers) to encourage use without disrupting workflow. The WHO’s "Guidelines on Hand Hygiene in Health Care" (2009) suggest providing skin care products as part of a multimodal strategy to enhance adherence, making this a proactive, facility-supported solution that addresses the root cause.

Option A, "Provide staff lotion in every patient room," is a good intention but impractical and potentially risky. Placing lotion in patient rooms could lead to inconsistent use, contamination (e.g., from patient contact), or misuse (e.g., staff applying incompatible products), compromising infection control. The CDC advises against uncontrolled lotion distribution in patient care areas. Option C, "Allow staff to bring in lotion and carry it in their pockets," introduces variability in product quality and compatibility. Personal lotions may contain ingredients (e.g., oils) that inactivate alcohol-based sanitizers, and pocket storage increases the risk of contamination or cross-contamination, which the CDC cautions against. Option D, "Allow staff to bring in lotion for use at the nurses’ station and lounge," limits the intervention to non-patient care areas, reducing its impact on hand hygiene during patient interactions. It also shares the compatibility and contamination risks of Option C, making it less effective.

The CBIC Practice Analysis (2022) and CDC guidelines emphasize evidence-based interventions, such as providing approved skin care products in strategic locations to boost compliance. Option B balances accessibility, safety, and compatibility, making it the best step to address hand dryness and improve hand hygiene rates.

The correct answer is B, "Competence," as it defines the essential knowledge, behaviors, and skills that an individual should possess and demonstrate to practice in a specific discipline. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, competence encompasses the integrated application of knowledge, skills, and behaviors required to perform effectively in a professional role, such as infection prevention and control. Competence goes beyond mere knowledge or training by including the ability to apply these attributes in real-world scenarios, ensuring safe and effective practice (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.3 - Assess competence of healthcare personnel). This holistic definition is critical in healthcare settings, where demonstrated competence—through actions like proper hand hygiene or outbreak management—directly impacts patient safety and infection prevention outcomes.

Option A (certification) refers to a formal recognition or credential (e.g., CIC certification) that validates an individual’s qualifications, but it is an outcome or process rather than the definition of the underlying abilities. Option C (knowledge) represents the theoretical understanding or factual basis of a discipline, which is a component of competence but not the full scope that includes behaviors and skills. Option D (training) involves the education or instruction provided to develop skills and knowledge, serving as a means to achieve competence rather than defining it.

The focus on competence aligns with CBIC’s emphasis on ensuring that healthcare personnel are equipped to meet the demands of infection prevention through a combination of education, practice, and evaluation (CBIC Practice Analysis, 2022, Domain IV: Education and Research, Competency 4.2 - Evaluate the effectiveness of educational programs). This definition supports the development of professionals who can adapt and perform effectively in dynamic healthcare environments.

When an infection preventionist (IP) is informed of a measles outbreak in a nearby community, the immediate priority is to protect healthcare workers and patients from potential exposure, particularly in a healthcare setting where vulnerable populations are present. Working with Occupational Health, the IP must follow a structured approach to mitigate the risk of transmission, guided by principles from the Certification Board of Infection Control and Epidemiology (CBIC) and public health guidelines. Let’s evaluate each option to determine the first priority:

A. Isolate employees who have recently traveled to areas with measles outbreaks: Isolating employees who may have been exposed to measles during travel is an important infection control measure to prevent transmission within the facility. However, this action assumes that exposure has already occurred and requires identification of affected employees first. Without knowing the immunity status of the workforce, this step is reactive rather than preventive and cannot be the first priority.

B. Reassign employees who are pregnant from caring for patients with suspected measles: Reassigning pregnant employees is a protective measure due to the severe risks measles poses to fetuses (e.g., congenital rubella syndrome risks, though measles itself is more about maternal complications). This action is specific to a subset of employees and depends on identifying patients with suspected measles, which may not yet be confirmed. It is a secondary step that follows assessing overall immunity and exposure risks, making it inappropriate as the first priority.

C. Verify that employees in high-risk exposure areas of the facility have adequate immunity to measles: Verifying immunity is the foundational step in preventing measles transmission in a healthcare setting. Measles is highly contagious, and healthcare workers in high-risk areas (e.g., emergency departments, pediatric wards) are at increased risk of exposure. The CBIC and CDC recommend ensuring that all healthcare personnel have documented evidence of measles immunity (e.g., two doses of MMR vaccine, laboratory evidence of immunity, or prior infection) as a primary infection control strategy during outbreaks. This step allows the IP to identify vulnerable employees, implement targeted interventions, and comply with occupational health regulations. It is the most proactive and immediate priority when an outbreak is reported in the community.

D. Set up a mandatory vaccination clinic in collaboration with Occupational Health and local public health partners: Establishing a vaccination clinic is a critical long-term strategy to increase immunity and control the outbreak. However, this requires planning, resource allocation, and coordination, which take time. It is a subsequent step that follows verifying immunity status to identify those who need vaccination. While important, it cannot be the first priority due to its logistical demands.

The first priority is C, as verifying immunity among employees in high-risk areas establishes a baseline to prevent transmission before reactive measures (e.g., isolation, reassignment) or broader interventions (e.g., vaccination clinics) are implemented. This aligns with CBIC’s focus on proactive risk assessment and occupational health safety during infectious disease outbreaks, ensuring a rapid response to protect the healthcare workforce and patients.

CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III: Prevention and Control of Infectious Diseases, which prioritizes immunity verification during outbreaks.

CBIC Examination Content Outline, Domain IV: Environment of Care, which includes ensuring employee immunity as part of outbreak preparedness.

CDC Guidelines for Measles Prevention (2023), which recommend verifying healthcare worker immunity as the initial step during a measles outbreak.

The correct answer is A, "Pertussis," as healthcare personnel should suspect this condition based on the presented symptoms and the patient’s incomplete vaccination history. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, pertussis, caused by the bacterium Bordetella pertussis, is characterized by an initial phase of mild respiratory symptoms (e.g., runny nose, low-grade fever) followed by a distinctive uncontrollable, rapid, and violent cough, often described as a "whooping" cough. This presentation is particularly concerning in adults with incomplete vaccination histories, as the pertussis vaccine’s immunity (e.g., DTaP or Tdap) wanes over time, increasing susceptibility (CBIC Practice Analysis, 2022, Domain I: Identification of Infectious Disease Processes, Competency 1.1 - Identify infectious disease processes). Pertussis is highly contagious and poses a significant risk in healthcare settings, necessitating prompt suspicion and isolation to prevent transmission.

Option B (rhinovirus) typically causes the common cold with symptoms like runny nose, sore throat, and mild cough, but it lacks the violent, paroxysmal cough characteristic of pertussis. Option C (bronchitis) may involve cough and fever, often due to viral or bacterial infection, but it is not typically associated with the rapid and violent cough pattern or linked to vaccination status in the same way as pertussis. Option D (adenovirus) can cause respiratory symptoms, including cough and fever, but it is more commonly associated with conjunctivitis or pharyngitis and does not feature the hallmark violent cough of pertussis.

The suspicion of pertussis aligns with CBIC’s emphasis on recognizing infectious disease patterns to initiate timely infection control measures, such as droplet precautions and prophylaxis for exposed individuals (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents). Early identification is critical, especially in healthcare settings, to protect vulnerable patients and staff, and the incomplete vaccination history supports this differential diagnosis given pertussis’s vaccine-preventable nature (CDC Pink Book: Pertussis, 2021).

The CBIC Certified Infection Control Exam Study Guide (6th edition) clearly states that steam sterilization (moist heat sterilization) must be validated using biological indicators containing Geobacillus stearothermophilus spores. This organism is selected because its spores are highly resistant to moist heat, making them an ideal challenge organism for assessing the effectiveness of steam sterilization processes.

Biological indicators are used to confirm that sterilization conditions—such as temperature, pressure, and exposure time—are sufficient to achieve microbial inactivation. Geobacillus stearothermophilus thrives at high temperatures and demonstrates strong resistance to steam, so if these spores are destroyed, it provides high confidence that other less-resistant microorganisms, including bacteria, viruses, and fungi, have also been eliminated.

The other options are incorrect for steam sterilization validation. Staphylococcus aureus is a vegetative bacterium and is far less resistant than bacterial spores. Bacillus anthracis is not used as a biological indicator due to safety concerns and lack of standardization. Bacillus atrophaeus is used as the biological indicator for dry heat and ethylene oxide sterilization, not steam.

Understanding which biological indicators correspond to specific sterilization modalities is a high-yield topic on the CIC® exam and is essential for ensuring compliance with evidence-based sterilization and disinfection standards.

=======

The correct answer is D, "Hepatitis B immune globulin (HBIG) and hepatitis B vaccine," as this is the recommended regimen for an HBsAb-negative employee with a percutaneous exposure to blood from an HBsAg-positive patient. According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, which align with recommendations from the Centers for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP), post-exposure prophylaxis (PEP) for hepatitis B virus (HBV) exposure depends on the employee’s vaccination status and the source’s HBsAg status. For an unvaccinated or known HBsAb-negative individual (indicating no immunity) exposed to HBsAg-positive blood, the standard PEP includes both HBIG and the hepatitis B vaccine. HBIG provides immediate passive immunity by delivering pre-formed antibodies, while the vaccine initiates active immunity to prevent future infections (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.2 - Implement measures to prevent transmission of infectious agents). The HBIG should be administered within 24 hours of exposure (preferably within 7 days), and the first dose of the vaccine should be given concurrently, followed by the complete vaccine series.

Option A (immune serum globulin and hepatitis B vaccine) is incorrect because immune serum globulin (ISG) is a general immunoglobulin preparation and not specific for HBV; HBIG, which contains high titers of anti-HBs, is the appropriate specific immunoglobulin for HBV exposure. Option B (hepatitis B immune globulin [HBIG] alone) is insufficient, as it provides only temporary passive immunity without initiating long-term active immunity through vaccination, which is critical for an unvaccinated individual. Option C (hepatitis B vaccine alone) is inadequate for immediate post-exposure protection, as it takes weeks to develop immunity, leaving the employee vulnerable in the interim.

The recommendation for HBIG and hepatitis B vaccine aligns with CBIC’s emphasis on evidence-based post-exposure management to prevent HBV transmission in healthcare settings (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.1 - Collaborate with organizational leaders). This dual approach is supported by CDC guidelines, which prioritize rapid intervention to reduce the risk of seroconversion following percutaneous exposure (CDC Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV, 2013).